Double Win for Reading Horizons in Prestigious 2025 Readers' Choice Awards
KAYSVILLE, Utah, June 05, 2025--(BUSINESS WIRE)--Reading Horizons®, a leader in foundational literacy, is proud to announce that two of its flagship products received top honors in the 2025 Readers' Choice Awards presented by SmartBrief on EdTech. Each year, the publication's audience of educators and administrators highlights the most innovative and effective education solutions through these awards. They choose winners based on how well the solutions drive meaningful outcomes and advance learning through creativity and technology.
Early Education Category Winner, Reading Horizons Discovery:
Reading Horizons Discovery Product Suite, built for K–3 learners, earned recognition for its structured, science-based approach that actively helps early readers build a strong foundation in phonics, decoding, and language development. The program provides educators with practical tools and clear guidance to foster capable readers during the most critical years of literacy development.
Reading and Literacy Instruction Winner, Reading Horizons Elevate Express Track:
Reading Horizons Elevate Express Track, designed for students in grades 4–12, earned recognition for transforming adolescent literacy. The program streamlines phonics instruction and accelerates skill development, equipping educators with the strategies and resources needed to help striving readers close reading gaps quickly through efficient, evidence-based teaching.
"We're thrilled to see our solutions recognized in two critical categories of literacy instruction," said Trisha Thomas, President at Reading Horizons. "What makes these awards especially meaningful is that they come directly from educators and administrators—the very people using our solutions every day in their classrooms. Their validation reaffirms the real-world impact we're making in classrooms across the country."
SmartBrief's editorial team commented: "The reader-selected awards honor education tools that drive real change. The 2025 winners represent the best of the best in edtech, and each honoree should be incredibly proud."
SmartBrief Education Originals features award coverage on its website and in its newsletters, highlighting Reading Horizons alongside other standout innovations in edtech.
To learn more about Reading Horizons' award-winning literacy solutions for early and older learners, visit Reading Horizons.
About Reading Horizons
For over 40 years, Reading Horizons® has equipped educators to combat illiteracy with innovative, tech-enabled foundational reading instruction. Grounded in the latest science of reading research, Reading Horizons provides effective K–12 literacy solutions and leads the Science of Reading Collective, a collaborative community for educators to share best practices and insights.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250605336228/en/
Contacts
Media Inquiries:Kelley K. Johnsonkelley.johnson@readinghorizons.com (801) 368.1183
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Associated Press
3 hours ago
- Associated Press
GC Biopharma Signs MOU with Thai Red Cross Society to Strengthen Collaboration on Plasma-Derived Therapies
YONGIN, South Korea, Aug. 18, 2025 /PRNewswire/ -- GC Biopharma ( a South Korean biopharmaceutical company, announced today that it has signed a Memorandum of Understanding (MOU) with the Thai Red Cross Society (TRCS) to cooperate on workforce training for the production of plasma-derived medicinal products. This MOU formalizes and deepens a relationship that began in 2015, when GC Biopharma supported TRCS to establish a plasma fractionation facility in Thailand, and reflects the ongoing strategic collaboration between the two parties. Under the terms of the MOU, GC Biopharma and TRCS will jointly develop and operate on-site training and exchange programs for local production personnel. These programs aim to transfer GC Biopharma's advanced manufacturing technologies and expertise to support the development of local capabilities. In addition, both parties intend to continue identifying and expanding collaborative opportunities that align with their respective strengths and interests. The scope of cooperation will be gradually broadened to include potential joint projects such as the transfer of new processing technologies for plasma by-products and other strategic projects. 'This MOU is a significant step in broadening the reach of GC Biopharma's advanced technology and production standards across Asia,' said Hyoungjun Park, Vice President of GC Biopharma. 'Through our collaboration with the TRCS, we aim to achieve mutual growth while contributing to the public good.' 'Enhancing our personnel's capabilities through specialized training and direct knowledge transfer from GC Biopharma is essential to maintaining the quality, safety, and continuity of plasma-derived medicinal products production in Thailand,' said Assoc. Prof. Dootchai Chaiwanichsiri, Director of the National Blood Centre, TRCS. 'This collaboration not only supports the human resource development but also represents an important step for technology transfer and playing a vital role in strengthening the country's pharmaceutical and public health security.' Meanwhile, GC Biopharma continues to expand its global plasma-derived therapeutics business. In addition to entering the U.S. immunoglobulin market in 2024, the company is actively building partnerships in Southeast Asia, where domestic fractionation capabilities remain limited. About GC Biopharma GC Biopharma (formerly known as Green Cross Corporation) is a biopharmaceutical company headquartered in Yong-in, South Korea. The company has over half a century of experience in the development and manufacturing of plasma derivatives and vaccines, and is expanding its global presence with successful US market entry of Alyglo® (intravenous immunoglobulin G) in 2024. In line with its mission to meet the demands of future healthcare, GC Biopharma continues to drive innovation by leveraging its core R&D capabilities in engineering of proteins, mRNAs, and lipid nanoparticle (LNP) drug delivery platform to develop therapeutics for the field of rare disease as well as I&I (Immunology & Inflammation). To learn more about the company, visit This press release may contain biopharmaceuticals in forward-looking statements, which express the current beliefs and expectations of GC Biopharma's management. Such statements do not represent any guarantee by GC Biopharma or its management of future performance and involve known and unknown risks, uncertainties, and other factors. GC Biopharma undertakes no obligation to update or revise any forward-looking statement contained in this press release or any other forward-looking statements it may make, except as required by law or stock exchange rule. GC Biopharma Contacts (Media) Sohee Kim [email protected] Yelin Jun [email protected] Yoonjae Na [email protected] View original content to download multimedia: SOURCE GC Biopharma
Yahoo
4 hours ago
- Yahoo
Mitsubishi Electric's Net Zero Energy Building Test Facility "SUSTIE" is Asian Regional Winner in ASHRAE Technology Awards Program
TOKYO, August 18, 2025--(BUSINESS WIRE)--Mitsubishi Electric Corporation, Mitsubishi Jisho Design Inc. and Waseda University jointly announced today that Mitsubishi Electric's Net Zero Energy Building Test Facility "SUSTIE," located in Kamakura, Kanagawa prefecture, was selected as Regional Winner (Regional Level Technology Awards 2025-2026 Regional Winner) in the Commercial Buildings (new) category of the ASHRAE® Technology Awards program. Organized by the Asian Region (ASHRAE Region XIII) of The American Society of Heating, Refrigerating and Air-Conditioning Engineers (ASHRAE), the program is one of the world's biggest technology award initiatives focusing on environmentally friendly building design. ASHRAE Technology Awards, one of the world's biggest technology awards program for environmentally friendly buildingsThe ASHRAE Technology Awards program, held annually since 1999, is one of the world's biggest such programs, recognizing innovative environmentally-friendly buildings for their occupant comfort, indoor air quality and energy conservation, with evaluations based on the building's verifiable operating data. In the Asian region selection, SUSTIE was the Regional Winner in the New Commercial Buildings category at the ASHRAE Region XIII Chapters Regional Conference. This award will ensure SUSTIE is reviewed by ASHRAE as a representative project of the Asian region in the worldwide selection process. Mitsubishi Electric, Mitsubishi Jisho Design and Waseda University will continue in their efforts to realize "the World's Most Environmentally Friendly Building." ASHRAE: American Society of Heating, Refrigerating and Air-Conditioning Engineers (based in Atlanta, US) was established in 1894, and is the largest international body focusing on air conditioning. It has more than 50,000 members across more than 130 nations. For the full text, please visit: View source version on Contacts Mitsubishi Electric Corporation Public Relations DivisionE-mail: Mitsubishi Jisho Design Inc. Corporate Planning Department Public Relations OfficeTEL: +81-3-3287-5001 Waseda University Public Relation OfficeTEL: +81-3-3202-5454 Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data


Business Wire
4 hours ago
- Business Wire
Mitsubishi Electric's Net Zero Energy Building Test Facility 'SUSTIE' is Asian Regional Winner in ASHRAE Technology Awards Program
TOKYO--(BUSINESS WIRE)--Mitsubishi Electric Corporation, Mitsubishi Jisho Design Inc. and Waseda University jointly announced today that Mitsubishi Electric's Net Zero Energy Building Test Facility 'SUSTIE,' located in Kamakura, Kanagawa prefecture, was selected as Regional Winner (Regional Level Technology Awards 2025-2026 Regional Winner) in the Commercial Buildings (new) category of the ASHRAE ® Technology Awards program. Organized by the Asian Region (ASHRAE Region XIII) of The American Society of Heating, Refrigerating and Air-Conditioning Engineers (ASHRAE), the program is one of the world's biggest technology award initiatives focusing on environmentally friendly building design. ASHRAE Technology Awards, one of the world's biggest technology awards program for environmentally friendly buildings The ASHRAE Technology Awards program, held annually since 1999, is one of the world's biggest such programs, recognizing innovative environmentally-friendly buildings for their occupant comfort, indoor air quality and energy conservation, with evaluations based on the building's verifiable operating data. In the Asian region selection, SUSTIE was the Regional Winner in the New Commercial Buildings category at the ASHRAE Region XIII Chapters Regional Conference. This award will ensure SUSTIE is reviewed by ASHRAE as a representative project of the Asian region in the worldwide selection process. Mitsubishi Electric, Mitsubishi Jisho Design and Waseda University will continue in their efforts to realize 'the World's Most Environmentally Friendly Building.' ASHRAE: American Society of Heating, Refrigerating and Air-Conditioning Engineers (based in Atlanta, US) was established in 1894, and is the largest international body focusing on air conditioning. It has more than 50,000 members across more than 130 nations. For the full text, please visit: